Francis K Buadi MD

Hematologic Oncology

Assistant Professor, Internal Medicine, Mayo Medical School

200 1st St SwRochester, MN 55905
Phone+1 507-284-2511

Dr. Buadi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buadi's full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and ScienceFellowship, Blood & Bone Marrow Transplant, 2002 - 2003
University of MarylandFellowship, Hematology and Medical Oncology, 1999 - 2002
St Agnes HealthCareResidency, Internal Medicine, 1996 - 1999
University of Science and Technology SOMClass of 1991
School of Medical Sciences, University of Science and TechnologyB.S., 1984 - 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 2002 - 2027
MD State Medical License 1999 - 2008
TN State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017

Publications & Presentations

PubMed

Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, Prashant Kapoor, Guneet Janda
American Journal of Hematology. 2026-09-01
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.
Y Lisa Hwa, Dragan Jevremovic, Karen Pak, Prashant Kapoor, Alissa Visram
British Journal of Haematology. 2026-08-02
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.
Maximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, Sara Oubari, Murielle Roussel
American Journal of Hematology. 2026-08-01

Journal Articles

Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma
S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation
Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse
Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature

Books/Book Chapters

Multiple myeloma: diagnosed and treatment
Chapter: Management of treatment complications and supportive care
Page 159 - 177Buadi FK, Chanan Khan AEditors: Gertz MA; Rajkumar SV.Springer, New York, NY2014
Wintrobe's clinical hematology
Chapter: Practical approch to evaluation of monoclonal gammopathies
Page 2014 - 2021Buadi FK, Mikhael JR, Morice WGWolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PAEdition 13th,2014
Hematology: basic principles and practice
Chapter: Immunoglobin light-chain amyloidosis (primary amyloidosis)
Page 1350 - 1374Gertz MA, Buadi FK, Zeldenrust SR, Hayman SREditors: Hoffman R; et al.Saunders/Elsevier, Philadelphia, PAEdition 6th,2013

Abstracts/Posters

A phase ll study (px-171-003-a1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma
Siegel D, Martin T, Wang M, Vij R, Jakubowiak A, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu F, Somlo G, Zonder J, Stewart AK, Stad..., Onkologie, 10/1/2013
Prediction of poor mobilization of autologous cd34+cells in multiple myeloma (mm): implications for risk-stratification
Costa LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, Kang Y, Gertz MA, Stuart RK, Kumar SK, Transfusion, 9/1/2013
A phase II study (PX-171-003-A1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma (rrmm)
Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu FJ, Somlo G, Zonder J, Song K, Stewa..., Br J Haematol, 4/1/2013

Lectures

Hematologic Malignancies: New Therapies and the Evolving Role of Transplant
Mayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013
Hematologic Malignancies: New Therapies and the Evolving Role of Transplant
Mayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013

Other

Vital statistics, maternal mortality and causes of childhood mortality in the Tanoso district, Brong Ahafo region, Ghana (Thesis)
Buadi FK, School of Medical Sciences, University of Science and Technology
Kumasi, Ghana - 8/1/1990
Polyclonal Hypergammaglobulinemia
Buadi FK, Ask Mayo Expert
http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=4592